Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nicholls

Showing results (1341-1350 of 1,396) with videos related to

Pageof 140
Sort By:
Energy & Environmental Science|October 14, 2024
Distinguishing bulk redox from near-surface degradation in lithium nickel oxide cathodesLijin An, Jack E N Swallow, Peixi Cong, et al.
Journal of Diabetes and Its Complications|September 23, 2023
The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trialYu Kataoka, Satoshi Kitahara, Sayaka Funabashi, et al.
Atherosclerosis|August 16, 2025
Apolipoprotein CIII in statin-treated type 2 diabetic patients: Its implications for plaque progression and instability: The pre-specified analysis from the OPTIMAL randomized controlled trialSatoshi Kitahara, Yu Kataoka, Stephen J Nicholls, et al.
Atherosclerosis|October 16, 2025
Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysisJedidiah I Morton, Florian Kronenberg, Magdalena Daccord, et al.
Cardiovascular Research|August 27, 2024
Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarctionPeter J Psaltis, Mau T Nguyen, Kuljit Singh, et al.
Journal of Clinical Lipidology|January 21, 2026
Different response of plaque regression following achievement of LDL-C <1.8 mmol/L in obese and non-obese patients with diabetes and coronary artery disease: OPTIMAL sub-analysisAnthony Salib, Yu Kataoka, Stephen J Nicholls, et al.
European Journal of Preventive Cardiology|September 13, 2024
Global burden of cardiovascular diseases: projections from 2025 to 2050Bryan Chong, Jayanth Jayabaskaran, Silingga Metta Jauhari, et al.
Journal of the American College of Cardiology|September 4, 2024
ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II TrialC Michael Gibson, Gerald Chi, Danielle Duffy, et al.
Journal of the American College of Cardiology|May 22, 2024
Personalized Intervention Based on Early Detection of Atherosclerosis: JACC State-of-the-Art ReviewRikke V Nielsen, Valentin Fuster, Henning Bundgaard, et al.
The New England Journal of Medicine|December 17, 2025
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 DiabetesStephen J Nicholls, Imre Pavo, Deepak L Bhatt, et al.
Pageof 140

Showing results (1341-1350 of 1,396) with videos related to

Sort By:
Pageof 140
Energy & Environmental Science|October 14, 2024
Distinguishing bulk redox from near-surface degradation in lithium nickel oxide cathodesLijin An, Jack E N Swallow, Peixi Cong, et al.
Journal of Diabetes and Its Complications|September 23, 2023
The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trialYu Kataoka, Satoshi Kitahara, Sayaka Funabashi, et al.
Atherosclerosis|August 16, 2025
Apolipoprotein CIII in statin-treated type 2 diabetic patients: Its implications for plaque progression and instability: The pre-specified analysis from the OPTIMAL randomized controlled trialSatoshi Kitahara, Yu Kataoka, Stephen J Nicholls, et al.
Atherosclerosis|October 16, 2025
Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysisJedidiah I Morton, Florian Kronenberg, Magdalena Daccord, et al.
Cardiovascular Research|August 27, 2024
Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarctionPeter J Psaltis, Mau T Nguyen, Kuljit Singh, et al.
Journal of Clinical Lipidology|January 21, 2026
Different response of plaque regression following achievement of LDL-C <1.8 mmol/L in obese and non-obese patients with diabetes and coronary artery disease: OPTIMAL sub-analysisAnthony Salib, Yu Kataoka, Stephen J Nicholls, et al.
European Journal of Preventive Cardiology|September 13, 2024
Global burden of cardiovascular diseases: projections from 2025 to 2050Bryan Chong, Jayanth Jayabaskaran, Silingga Metta Jauhari, et al.
Journal of the American College of Cardiology|September 4, 2024
ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II TrialC Michael Gibson, Gerald Chi, Danielle Duffy, et al.
Journal of the American College of Cardiology|May 22, 2024
Personalized Intervention Based on Early Detection of Atherosclerosis: JACC State-of-the-Art ReviewRikke V Nielsen, Valentin Fuster, Henning Bundgaard, et al.
The New England Journal of Medicine|December 17, 2025
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 DiabetesStephen J Nicholls, Imre Pavo, Deepak L Bhatt, et al.
Pageof 140